2026 Stevan R. Hubbard: Biology and Biochemistry Researcher – H-Index, Publications & Awards

D-Index & Metrics

Discipline name	D-Index	World Ranking	Current World Ranking	National Ranking	Current National Ranking	Publications	Citations
Biology and Biochemistry	66	8468	7819	3808	3422	161	24222

Discipline name

D-Index

World Ranking

Current World Ranking

National Ranking

Current National Ranking

Publications

Citations

Biology and Biochemistry

8468

7819

3808

3422

161

24222

Biology and Biochemistry

D-Index

Citations

24222

World Ranking

8468

National Ranking

3808

Overview

Stevan R. Hubbard is affiliated with New York University in the United States. Their research spans multiple disciplines within medicine and biochemistry, genetics, and molecular biology.

The scientist has contributed extensively in the following fields of study:

Medicine
Biochemistry, Genetics and Molecular Biology

Their work emphasizes several subfields, including:

Genetics
Immunology
Infectious Diseases
Molecular Biology
Oncology

Key topics covered in their research include:

Cytokine Signaling Pathways and Interactions
Protein Kinase Regulation and GTPase Signaling
Monoclonal and Polyclonal Antibodies Research
SARS-CoV-2 and COVID-19 Research
Virus-based gene therapy research
SARS-CoV-2 detection and testing
Myeloproliferative Neoplasms: Diagnosis and Treatment

Stevan R. Hubbard has published multiple research articles in well-known journals and repositories. Notable recent papers include:

Mechanism of homodimeric cytokine receptor activation and dysregulation by oncogenic mutations, 2020, Science
Increased resistance of SARS-CoV-2 Omicron variant to neutralization by vaccine-elicited and therapeutic antibodies, 2022, EBioMedicine
Structural basis of Janus kinase trans-activation, 2023, Cell Reports
Increased resistance of SARS-CoV-2 Omicron Variant to Neutralization by Vaccine-Elicited and Therapeutic Antibodies, 2021, bioRxiv (Cold Spring Harbor Laboratory)
Identification of Novel Small Molecule Ligands for JAK2 Pseudokinase Domain, 2023, Pharmaceuticals

Frequent publication venues for this scientist include:

Science
bioRxiv (Cold Spring Harbor Laboratory)
EBioMedicine
Cell Reports
Pharmaceuticals

Stevan R. Hubbard has collaborated regularly with the following researchers:

K. Christopher García
Takuya Tada
Hao Zhou
Belinda M. Dcosta
Marie I. Samanovic

Best Publications

IRE1 couples endoplasmic reticulum load to secretory capacity by processing the XBP-1 mRNA

Marcella Calfon;Huiqing Zeng;Fumihiko Urano;Jeffery H Till

3230
Citations
Protein Tyrosine Kinase Structure and Function

Stevan R. Hubbard;Jeffrey H. Till

1562
Citations
Crystal structure of the tyrosine kinase domain of the human insulin receptor.

S. R. Hubbard;Lei Wei;L. Ellis;L. Ellis;W. A. Hendrickson;W. A. Hendrickson

1460
Citations
Structures of the tyrosine kinase domain of fibroblast growth factor receptor in complex with inhibitors.

Moosa Mohammadi;Gerald McMahon;Li Sun;Cho Tang

1375
Citations
Crystal structure of the activated insulin receptor tyrosine kinase in complex with peptide substrate and ATP analog.

Stevan R. Hubbard

1231
Citations
Catalytic specificity of protein-tyrosine kinases is critical for selective signalling

Zhou Songyang;Zhou Songyang;Kermit L. Carraway;Michael J. Eck;Stephen C. Harrison

1172
Citations
Structural basis for FGF receptor dimerization and activation.

Alexander N Plotnikov;Joseph Schlessinger;Stevan R Hubbard;Moosa Mohammadi

803
Citations
Lrp4 Is a Receptor for Agrin and Forms a Complex with MuSK

Natalie Kim;Amy L. Stiegler;Thomas O. Cameron;Peter T. Hallock

720
Citations
SU6668 Is a Potent Antiangiogenic and Antitumor Agent That Induces Regression of Established Tumors

A. Douglas Laird;Peter Vajkoczy;Laura K. Shawver;Andreas Thurnher

706
Citations
Receptor tyrosine kinases: mechanisms of activation and signaling

Stevan R Hubbard;W Todd Miller

648
Citations
Crystal structure of an angiogenesis inhibitor bound to the FGF receptor tyrosine kinase domain.

Moosa Mohammadi;Scott Froum;James M. Hamby;Mel C. Schroeder

608
Citations
Crystal Structures of Two FGF-FGFR Complexes Reveal the Determinants of Ligand-Receptor Specificity

Alexander N Plotnikov;Stevan R Hubbard;Joseph Schlessinger;Moosa Mohammadi

539
Citations
Structure of the FGF receptor tyrosine kinase domain reveals a novel autoinhibitory mechanism.

Moosa Mohammadi;Joseph Schlessinger;Stevan R Hubbard

538
Citations
Autoregulatory Mechanisms in Protein-tyrosine Kinases

Stevan R. Hubbard;Moosa Mohammadi;Joseph Schlessinger

470
Citations
Structure and autoregulation of the insulin-like growth factor 1 receptor kinase.

S Favelyukis;J.H Till;S.R Hubbard;W.T. Miller

435
Citations
Juxtamembrane autoinhibition in receptor tyrosine kinases

Stevan R Hubbard

405
Citations
Structural analysis of receptor tyrosine kinases.

Stevan R Hubbard

322
Citations
The Pseudokinase Domain of JAK2 Is a Dual-Specificity Protein Kinase That Negatively Regulates Cytokine Signaling

Daniela Ungureanu;Jinhua Wu;Jinhua Wu;Tuija Pekkala;Yashavanthi Niranjan

319
Citations
How IRE1 reacts to ER stress.

David Ron;Stevan R. Hubbard

296
Citations
Mechanism-based design of a protein kinase inhibitor.

Keykavous Parang;Jeffrey H. Till;Ararat J. Ablooglu;Ronald A. Kohanski

281
Citations